Epidemic strains of clostridium difficile are present in Auckland, New Zealand

New Zealand Medical Journal

Volumn 124, Issue 1332, 2011, Pages 97-101

  Roberts, Sally ^a   Heffernan, Helen ^b   Anbuky, Nadia Al ^c   Richardson, Alice ^d   Swager, Terri ^e   Taylor, Susan L ^f   Bower, James ^g   Williamson, Deborah ^h   Freeman, Joshua T ^f  

^a Clinical Head of Microbiology Department of Microbiology   (New Zealand)

^b Senior Scientist Nosocomial Infections Laboratory   (New Zealand)

^c Anaerobe Section Department of Microbiology   (New Zealand)

^d Scientist Nosocomial Infections Laboratory   (New Zealand)

^e Faecal Pathogens Department of Microbiology   (New Zealand)

^f Clinical Microbiologist Department of Microbiology   (New Zealand)

^g Scientist Molecular Section Department of Microbiology   (New Zealand)

^h Microbiology Registrar Department of Microbiology   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME IMMUNOASSAY; EPIDEMIC; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HOSPITALIZATION; HUMAN; MORTALITY; NEW ZEALAND; NONHUMAN; POLYMERASE CHAIN REACTION; RURAL AREA; SENSITIVITY ANALYSIS;

ANIMALS; ANIMALS, DOMESTIC; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER STATE; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; EPIDEMICS; GLUTAMATE DEHYDROGENASE; HUMANS; IMMUNOENZYME TECHNIQUES; MUTATION; NEW ZEALAND; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; REPRESSOR PROTEINS; RIBOTYPING; VIRULENCE;

EID: 79955536574     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile NEJM 2005; 353: 2433-41
2. Kuijper EJ, Coignard B, Tüll P on behalf of the ESCMID Study Group for Clostridium difficile, EU member States and the European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12:S2-18.
3. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust. 2009;190:706-8
4. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47:1162-70
5. Mulvey MR, Boyd DA, Gravel D, et al. Hypervirulent Clostridium difficile strains in hospitalised patients, Canada. Emerg Infect Dis. 2010;16:678-81.
6. Burns K, Morris-Downes M, Fawley WN, et al. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland. J Hosp Infect. 2010; 75:287-91.
7. Roberts S, Heffernan H, Al Anbuky N, et al. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009. N Z Med J 2011;124(1332). http://www.nzma.org.nz/journal/124-1332/4610
8. Clements ACA, Magalhães RJS, Tatem AJ, et al. Clostridium difficile PCR ribotype 027: assessing the risk of further worldwide spread. Lancet Infect Dis 2010;10:395-04.
9. Ferguson JK, McGregor A, Roberts S, et al. Testing for Clostridium difficile infection in Australia and New Zealand laboratories. Submitted for publication in Pathology, December 2010.
10. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile infection (CDI). Clin Microbiol Infect 2009;15:1053-6.